BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc 2018; 10(9): 165-174 [PMID: 30283599 DOI: 10.4253/wjge.v10.i9.165] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sullivan R, Mulki R, Peter S. The role of ablation in the treatment of dysplastic Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211049967. [PMID: 34708203 DOI: 10.1177/26317745211049967] [Reference Citation Analysis]
2 Ventre S, Shahid H. Endoscopic therapies for Barrett's esophagus. Transl Gastroenterol Hepatol 2021;6:62. [PMID: 34805584 DOI: 10.21037/tgh.2020.02.04] [Reference Citation Analysis]
3 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
4 Correia ACP, Straub D, Calpe S, Krishnadath KK. Novel In Vivo Mouse Cryoablation Model to Explore Unique Therapeutic Approaches for Premalignant Columnar Lesions. Methods Protoc 2021;4:6. [PMID: 33526760 DOI: 10.3390/mps4010006] [Reference Citation Analysis]
5 Correia ACP, Calpe S, Mostafavi N, Hoefnagel SJM, Sancho-Serra MDC, de Koning PS, Krishnadath KK. Detection of circulating BMP5 as a risk factor for Barrett's esophagus. Sci Rep 2020;10:15579. [PMID: 32968094 DOI: 10.1038/s41598-020-70760-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kim MS, Song IS, Oh KH, Cho JG, Baek SK, Woo JS, Jung KY, Kwon SY. The Utility of Gastrointestinal Endoscopic Examination Versus Positron Emission Tomography-Computed Tomography in the Detection of Second Primary Lesions in Korean Patients With Head and Neck Cancer. Ear Nose Throat J 2020;:145561320940089. [PMID: 32749871 DOI: 10.1177/0145561320940089] [Reference Citation Analysis]
7 Boškoski I, Hamanaka J, Barbaro F, Arena V, Mascagni P, Caristo ME, De Siena M, Gallo C, Costamagna G. Feasibility and safety of a new endoscopic synthetic sealant nebulizing device over gastric endoscopic submucosal dissections. Surg Endosc 2021;35:4048-54. [PMID: 33851265 DOI: 10.1007/s00464-021-08480-4] [Reference Citation Analysis]
8 Shimizu T, Samarasena JB, Fortinsky KJ, Hashimoto R, El Hage Chehade N, Chin MA, Moosvi Z, Chang KJ. Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett's esophagus: US pilot study. Endosc Int Open 2021;9:E1870-6. [PMID: 34917455 DOI: 10.1055/a-1492-2450] [Reference Citation Analysis]
9 Farina DA, Condon A, Komanduri S, Muthusamy VR. A Practical Approach to Refractory and Recurrent Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:183-203. [PMID: 33213795 DOI: 10.1016/j.giec.2020.09.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Junquera F, Fernández-Ananín S, Balagué C. Therapeutic options for early cancer of the esophagogastric junction. Cir Esp (Engl Ed) 2019;97:438-44. [PMID: 31138450 DOI: 10.1016/j.ciresp.2019.04.001] [Reference Citation Analysis]
11 Medina AL, Troendle DM, Park JY, Thaker A, Dunbar KB, Cheng E. Eosinophilic esophagitis, Barrett's esophagus and esophageal neoplasms in the pediatric patient: a narrative review. Transl Gastroenterol Hepatol 2021;6:32. [PMID: 34423153 DOI: 10.21037/tgh-20-223] [Reference Citation Analysis]
12 Zhang S, Orita H, Fukunaga T. Current surgical treatment of esophagogastric junction adenocarcinoma. World J Gastrointest Oncol 2019; 11(8): 567-578 [PMID: 31435459 DOI: 10.4251/wjgo.v11.i8.567] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Neuberg M, Blanchet M, Gignoux B, Frering V. Long-Term Outcomes After One-Anastomosis Gastric Bypass (OAGB) in Morbidly Obese Patients. OBES SURG 2020;30:1379-84. [DOI: 10.1007/s11695-019-04287-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]